127 related articles for article (PubMed ID: 15086486)
21. Angiotensin II plays an important role in maintaining blood pressure in postmenopausal women receiving hormone replacement therapy.
Sumino H; Ichikawa S; Miya Y; Sakamaki T; Kurabayashi M
Am J Hypertens; 2005 Oct; 18(10):1340-6. PubMed ID: 16202859
[TBL] [Abstract][Full Text] [Related]
22. Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.
Stankovic AR; Fisher ND; Hollenberg NK
J Am Soc Nephrol; 2006 Dec; 17(12):3293-9. PubMed ID: 17093063
[TBL] [Abstract][Full Text] [Related]
23. [The angiotensin II inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy].
Shamkhlova MSh; Trubitsyna NP; Katsaia GV; Goncharov NP; Malysheva NM; Il'in AV; Nikankina LV; Koshel' LV; Shestakova MV
Ter Arkh; 2008; 80(1):49-52. PubMed ID: 18326228
[TBL] [Abstract][Full Text] [Related]
24. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
25. Relationship between plasma renin, renin-substrate, angiotensin II, aldosterone and electrolytes in normal pregnancy.
Wier RJ; Brown JJ; Fraser R; Lever AF; Logan RW; McIlwaine GM; Morton JJ; Robertson JI; Tree M
J Clin Endocrinol Metab; 1975 Jan; 40(1):108-15. PubMed ID: 234473
[No Abstract] [Full Text] [Related]
26. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
[TBL] [Abstract][Full Text] [Related]
27. Identifying a disease-specific renin-angiotensin-aldosterone system fingerprint in patients with primary adrenal insufficiency.
Wolf P; Mayr J; Beiglböck H; Fellinger P; Winhofer Y; Poglitsch M; Gessl A; Kautzky-Willer A; Luger A; Krebs M
Eur J Endocrinol; 2019 Jul; 181(1):39-44. PubMed ID: 31075757
[TBL] [Abstract][Full Text] [Related]
28. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system.
Gammelgaard I; Wamberg S; Bie P
Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800
[TBL] [Abstract][Full Text] [Related]
29. Adrenal responses to pharmacological interruption of the renin-angiotensin system in sodium-restricted normal man.
Williams GH; Hollenberg NK; Brown C; Mersey JH
J Clin Endocrinol Metab; 1978 Oct; 47(4):725-31. PubMed ID: 400731
[TBL] [Abstract][Full Text] [Related]
30. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
McCaa RE
Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
Nicholls MG; Espiner EA; Donald RA
J Lab Clin Med; 1976 Jun; 87(6):1005-15. PubMed ID: 180213
[TBL] [Abstract][Full Text] [Related]
32. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
Speckart P; Zia P; Zipser R; Horton R
J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
Tsutamoto T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
Hypertens Res; 2010 Feb; 33(2):118-22. PubMed ID: 19927151
[TBL] [Abstract][Full Text] [Related]
34. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
[TBL] [Abstract][Full Text] [Related]
35. Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.
Lamarre-Cliche M; de Champlain J; Lacourcière Y; Poirier L; Karas M; Larochelle P
Am J Hypertens; 2005 Jan; 18(1):56-64. PubMed ID: 15691618
[TBL] [Abstract][Full Text] [Related]
36. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
Schjoedt KJ; Jacobsen P; Rossing K; Boomsma F; Parving HH
Horm Metab Res; 2005 Apr; 37 Suppl 1():4-8. PubMed ID: 15918104
[TBL] [Abstract][Full Text] [Related]
37. Selective hypoaldosteronism with hyperreninemia in a diabetic patient.
Morimoto S; Kim KS; Yamamoto I; Uchida K; Takeda R; Kornel L
J Clin Endocrinol Metab; 1979 Nov; 49(5):742-7. PubMed ID: 489714
[TBL] [Abstract][Full Text] [Related]
38. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
[TBL] [Abstract][Full Text] [Related]
39. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
[TBL] [Abstract][Full Text] [Related]
40. Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
Paton AM; Lever AF; Oliver NW; Medina A; Briggs JD; Morton JJ; Brown JJ; Robertson JI; Fraser R; Tree M; Gavras H
Clin Nephrol; 1975 Jan; 3(1):18-23. PubMed ID: 1126059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
